Mirae Asset Global ETFs Holdings
ANIK icon

Mirae Asset Global ETFs Holdings’s Anika Therapeutics ANIK Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.6K Buy
6,112
+136
+2% +$1.58K ﹤0.01% 2718
2025
Q4 		$57.4K Buy
5,976
+176
+3% +$1.69K ﹤0.01% 2897
2025
Q3 		$54.5K Sell
5,800
-1,012
-15% -$9.66K ﹤0.01% 2924
2025
Q2 		$72.1K Sell
6,812
-1,015
-13% -$12.8K ﹤0.01% 2760
2025
Q1 		$118K Buy
7,827
+312
+4% +$5.19K ﹤0.01% 2556
2024
Q4 		$124K Buy
7,515
+304
+4% +$6K ﹤0.01% 2608
2024
Q3 		$178K Sell
7,211
-924
-11% -$24K ﹤0.01% 2419
2024
Q2 		$206K Buy
+8,135
New +$211K ﹤0.01% 2235

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ANIK Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Anika Therapeutics (ANIK) stake by 2.3% in Q1 2026, buying an estimated $1.58K and bringing the position to 6,112 shares worth $88.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2718.

Mirae Asset Global ETFs Holdings first reported a position in ANIK in Q2 2024 and has held it in 8 quarters since. The position peaked at $206K in Q2 2024. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 6,112 shares of Anika Therapeutics worth $88.6K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 136 Anika Therapeutics shares in Q1 2026, an estimated $1.58K.
  • Anika Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2718 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Anika Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Anika Therapeutics position peaked at $206K in Q2 2024.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.